|
1
|
Liu Y, Han X, Yu Y, Ding Y, Ni C, Liu W,
Hou X, Li Z, Hou J, Shen D, et al: A genetic polymorphism affects
the risk and prognosis of renal cell carcinoma: Association with
follistatin-like protein 1 expression. Sci Rep. 6:266892016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu Y, Zhang N, Li K, Chen H, Lin X, Yu Y,
Gou Y, Hou J, Jiang D, Na R, et al: Genetic scores based on
risk-associated single nucleotide polymorphisms (SNPs) can reveal
inherited risk of renal cell carcinoma. Oncotarget. 7:18631–18637.
2016.PubMed/NCBI
|
|
3
|
Lin YW, Lee LM, Lee WJ, Chu CY, Tan P,
Yang YC, Chen WY, Yang SF, Hsiao M and Chien MH: Melatonin inhibits
MMP-9 transactivation and renal cell carcinoma metastasis by
suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity. J
Pineal Res. 60:277–290. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hsieh JJ, Purdue MP, Signoretti S, Swanton
C, Albiges L, Schmidinger M, Heng DY, Larkin J and Ficarra V: Renal
cell carcinoma. Nat Rev Dis Primers. 3:170092017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou J, Yun EJ, Chen W, Ding Y, Wu K, Wang
B, Ding C, Hernandez E, Santoyo J, Pong RC, et al: Targeting
3-phosphoinositide-dependent protein kinase 1 associated with
drug-resistant renal cell carcinoma using new oridonin analogs.
Cell Death Dis. 8:e27012017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yoshino H, Seki N, Itesako T, Chiyomaru T,
Nakagawa M and Enokida H: Aberrant expression of microRNAs in
bladder cancer. Nat Rev Urol. 10:396–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ling H, Girnita L, Buda O and Calin GA:
Non-coding RNAs: The cancer genome dark matter that matters! Clin
Chem Lab Med. 55:705–714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cortés-Sempere M and de Cáceres Ibáñez I:
microRNAs as novel epigenetic biomarkers for human cancer. Clin
Transl Oncol. 13:357–362. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rotomskis A, Margevičiūtė R, Germanavičius
A, Kaubrys G, Budrys V and Bagdonas A: Differential diagnosis of
depression and Alzheimer's disease with the Addenbrooke's cognitive
Examination-revised (ACE-R). BMC Neurol. 15:572015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roomi MW, Kalinovsky T, Rath M and
Niedzwiecki A: In vitro modulation of MMP-2 and MMP-9 in pediatric
human sarcoma cell lines by cytokines, inducers and inhibitors. Int
J Oncol. 44:27–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lawless N, Vegh P, O'Farrelly C and Lynn
DJ: The role of microRNAs in bovine infection and immunity. Front
Immunol. 5:6112014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kefas B, Godlewski J, Comeau L, Li Y,
Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S and
Purow B: microRNA-7 inhibits the epidermal growth factor receptor
and the Akt pathway and is down-regulated in glioblastoma. Cancer
Res. 68:3566–3572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Won KY, Kim YW, Kim HS, Lee SK, Jung WW
and Park YK: MicroRNA-199b-5p is involved in the Notch signaling
pathway in osteosarcoma. Hum Pathol. 44:1648–1655. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Joshi D, Chandrakala S, Korgaonkar S,
Ghosh K and Vundinti BR: Down-regulation of miR-199b associated
with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive
CML patients. Gene. 542:109–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fang C, Wang FB, Li Y and Zeng XT:
Down-regulation of miR-199b-5p is correlated with poor prognosis
for breast cancer patients. Biomed Pharmacother. 84:1189–1193.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Favreau AJ, McGlauflin RE, Duarte CW and
Sathyanarayana P: miR-199b, a novel tumor suppressor miRNA in acute
myeloid leukemia with prognostic implications. Exp Hematol Oncol.
5:42016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang C, Song B, Song W, Liu J, Sun A, Wu
D, Yu H, Lian J, Chen L and Han J: Underexpressed microRNA-199b-5p
targets hypoxia-inducible factor-1α in hepatocellular carcinoma and
predicts prognosis of hepatocellular carcinoma patients. J
Gastroenterol Hepatol. 26:1630–1637. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu MX, Siu MK, Liu SS, Yam JW, Ngan HY
and Chan DW: Epigenetic silencing of microRNA-199b-5p is associated
with acquired chemoresistance via activation of JAG1-Notch1
signaling in ovarian cancer. Oncotarget. 5:944–958. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shang W, Chen X, Nie L, Xu M, Chen N, Zeng
H and Zhou Q: MiR199b suppresses expression of hypoxia-inducible
factor 1alpha (HIF-1α) in prostate cancer cells. Int J Mol Sci.
14:8422–8436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng H, Zhang Z, Dai X, Chen Y, Ye J and
Jin Z: Increased expression of microRNA-199b-5p associates with
poor prognosis through promoting cell proliferation, invasion and
migration abilities of human osteosarcoma. Pathol Oncol Res.
22:253–260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Andolfo I, Liguori L, De Antonellis P,
Cusanelli E, Marinaro F, Pistollato F, Garzia L, De Vita G,
Petrosino G, Accordi B, et al: The micro-RNA 199b-5p regulatory
circuit involves Hes1, CD15, and epigenetic modifications in
medulloblastoma. Neuro Oncol. 14:596–612. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tang J, Wang F, Cheng G, Si S, Sun X, Han
J, Yu H, Zhang W, Lv Q, Wei JF and Yang H: Wilms' tumor
1-associating protein promotes renal cell carcinoma proliferation
by regulating CDK2 mRNA stability. J Exp Clin Cancer Res.
37:402018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang M, Li C, Yu B, Su L, Li J, Ju J, Yu
Y, Gu Q, Zhu Z and Liu B: Overexpressed miR-301a promotes cell
proliferation and invasion by targeting RUNX3 in gastric cancer. J
Gastroenterol. 48:1023–1033. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Brodaczewska K, Szczylik C, Fiedorowicz M,
Porta C and Czarnecka AM: Choosing the right cell line for renal
cell cancer research. Mol Cancer. 15:832016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zaravinos A, Pieri M, Mourmouras N,
Anastasiadou N, Zouvani I, Delakas D and Deltas C: Altered
metabolic pathways in clear cell renal cell carcinoma: A
meta-analysis and validation study focused on the deregulated genes
and their associated networks. Oncoscience. 1:117–131. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Araújo Júnior RF, Oliveira Leitão AL,
de Melo Silveira RF, de Oliveira Rocha HA, de França Cavalcanti P
and de Araújo AA: Telmisartan induces apoptosis and regulates Bcl-2
in human renal cancer cells. Exp Biol Med (Maywood). 240:34–44.
2015. View Article : Google Scholar : PubMed/NCBI
|
